Allspring Global Investments
IRON icon

Allspring Global Investments’s Disc Medicine IRON Stock Holding History

Allspring Global Investments’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-232
Closed -$10.9K – 2477
2023
Q3 		$10.9K Buy
+232
New +$11.6K ﹤0.01% 2604
2022
Q2 		– Sell
-3,840
Closed -$160K – 2809
2022
Q1 		$160K Buy
3,840
+3,298
+608% +$173K ﹤0.01% 2643
2021
Q4 		$47K Buy
+542
New +$53.1K ﹤0.01% 2851

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Allspring Global Investments's IRON Position: Q4 2023 in Review

Allspring Global Investments sold out of Disc Medicine (IRON) in Q4 2023, closing a stake of 232 shares — an estimated $10.9K sold.

Allspring Global Investments first reported a position in IRON in Q4 2021 and held it in 3 quarters. The position peaked at $160K in Q1 2022. 112 funds tracked by Wall St. Rank hold IRON as of Q4 2023.

  • Allspring Global Investments reported no remaining Disc Medicine position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 232 Disc Medicine shares in Q4 2023, an estimated $10.9K.
  • Allspring Global Investments first reported a position in Disc Medicine in Q4 2021 and held it in 3 quarters.
  • Allspring Global Investments's Disc Medicine position peaked at $160K in Q1 2022.
  • 112 funds tracked by Wall St. Rank held Disc Medicine as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.